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The introduction of selective coronary angiography by
Mason Sones in the late 1950s revolutionized clinical
cardiology. Angiography, by allowing in vivo identification
of focal coronary stenoses in patients presenting with stable
and unstable coronary syndromes, has been the basis for the
enormous success of surgical and percutaneous revascular-
ization therapies. However, it was soon realized that the
mechanical treatment of focal lesions did not affect the
underlying systemic process of atherosclerosis (1). It was the
identification of clinical risk factors, including diabetes,
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smoking, hyperlipidemia, and hypertension, that led to
systemic therapeutic interventions that proved most effective
in preventing ischemic cardiovascular events (2–4). Despite
these important clinical advances, coronary artery disease
remains the number one cause of mortality in Western
societies (5). Obviously, current diagnostic and therapeutic
tools are inadequate to predict or prevent a large number of
acute cardiovascular events.
Atherosclerosis is a diffuse, systemic disease process that
typically begins many years before symptoms occur (6,7).
The dissociation between diffuse plaque accumulation and
focal, angiographic lesion appearance is explained by a
complex remodeling response of diseased arteries (8). Typ-
ically, the accumulating plaque burden is initially accommo-
dated by an expansion of the vessel area with minimal
changes in lumen size; a process called positive remodeling.
It is now generally accepted that sudden rupture or erosion
of such mildly stenotic but “vulnerable” lesions causes most
acute coronary syndromes (9). Animal and human studies
demonstrate that vulnerable plaques in coronary (10–13),
peripheral, and carotid arteries (14–17) are associated with
positive remodeling and intense inflammation. There is
strong evidence that a systemic inflammatory response plays
a central role in the destabilization of atherosclerotic lesions,
initiating plaque rupture and subsequent thrombosis
(18,19). Recent results in animal models and patients
presenting with acute coronary syndromes consistently
demonstrate simultaneous rupture of the culprit lesion and
multiple additional plaques at distant locations in the
coronary tree (20–24), supporting the existence of systemic
triggers causing acute plaque destabilization. It is unclear
why atherosclerotic lesions progress silently for extended
periods of time and then suddenly undergo changes leading
to rupture, thrombosis, and acute clinical syndromes. How-
ever, these acute changes are not limited to a single “culprit”
site but are part of a more diffuse, multicentric inflammatory
process involving the entire coronary tree, perhaps the
arterial vasculature in general. It is conceivable that the
combination of overall plaque burden and systemic triggers
correlates with the risk to develop acute clinical syndromes.
These findings have initiated a paradigm shift in our
approach to coronary atherosclerosis. Imaging of subclinical
atherosclerosis is used for the detection and quantification
of atherosclerotic plaque burden. However, the identifica-
tion of plaque without knowledge about disease “activity” is
not adequate for a comprehensive risk analysis because not
all atherosclerotic plaques result in coronary events. Disease
activity can be assessed by serologic markers that reflect the
systemic inflammatory response. In particular, high-
sensitivity C-reactive protein is increasingly incorporated in
risk assessment algorithms and has recently been compared
with traditional risk factors (19,25). A different approach is
the local assessment of atheroma activity. Accurate methods
identifying plaques with high-risk characteristics would
open the way for more aggressive systemic treatments and
potentially allow local mechanical treatments of the most
dangerous nonobstructive plaques.
However, the clinical diagnosis of plaque vulnerability is
a complex conundrum (26). Currently, neither invasive nor
noninvasive imaging technology can reliably identify vulner-
able plaques prospectively, that is, before rupture. Histologic
studies describe characteristic findings of such lesions,
which include a lipid-rich necrotic core with a thin fibrous
cap, a prominent inflammatory response, and positive re-
modeling (9–11). Because of their limited resolution, even
invasive imaging modalities cannot reliably identify minute
plaque structures in vivo. However, recent technical ad-
vances in ultrasound imaging use radiofrequency analysis
and elastography (27,28) and optical coherence tomography
(29) to characterize more precisely the composition of
atherosclerotic plaques. Yet another approach is the focal
assessment of temperature differences with sensitive intra-
vascular thermography catheters, presumably reflecting focal
inflammatory changes of vulnerable lesions (30,31). Even if
precise plaque characterization will be possible, the appli-
cability of these intravascular tools would be limited because
of their invasive nature. Thus, an accurate and easily
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applicable noninvasive tool that could characterize plaque
vulnerability would be an important step forward.
Noninvasive coronary imaging modalities, including
positron emission tomography (PET), magnetic resonance
imaging (MRI), and computed tomography (CT), generally
have a significantly lower resolution than invasive technol-
ogies, potentiating the limitations of tissue characterization
(26,32). However, future developments in plaque-specific
contrast media or fusion of, for example, CT and PET
imaging could provide additional information about lesion
vulnerability (33,34). Although in vivo tissue characteriza-
tion of vulnerable coronary atheroma remains difficult,
another feature consistently associated with vulnerability
can be assessed with invasive and noninvasive imaging
techniques. As stated in the preceding text, several histo-
logical studies describe a strong link between positive
remodeling, inflammation, and acute coronary syndromes
(10,11,14) This association has been confirmed in intravas-
cular ultrasound studies in vivo (12,13,35) and more re-
cently using the noninvasive imaging modalities, including
CT and MRI (26,36). Data describing the relationship
between remodeling and plaque vulnerability in vessels
other than the coronary are limited (14–16). In carotid
arteries, intima media thickness measurement has been
extensively studied as a means for atherosclerosis risk
assessment. Observational studies in large populations have
demonstrated that the noninvasive assessment of carotid
plaque burden is a marker for future coronary events (37,38).
Other studies show a correlation between carotid plaque
morphology and future events (39,40).
In this issue of the Journal, Kato et al. (41) explore this
relationship further by correlating remodeling characteris-
tics of carotid arteries with angiographically identified lesion
complexity in the coronary arteries. Patients were divided
into groups with single or multiple angiographically com-
plex coronary lesions. Using B-mode ultrasound of the
carotid arteries, the authors found a higher prevalence of
calcified and noncalcified carotid plaque in the group with
multiple complex coronary lesions. In addition, increased
carotid plaque thickness and positive remodeling was sig-
nificantly more frequent in patients with multiple versus
single complex coronary plaques. An important limitation of
this study is that the authors compare two groups of patients
presenting with acute coronary syndromes without a control
group of patients with stable coronary disease. The authors
assume that a higher number of complex coronary plaques
reflect a higher degree of vulnerability. Although plausible,
there is no proof of that concept, and the demonstrated
differences in carotid morphology may, for example, be
secondary to the significantly higher frequency of multives-
sel disease in the multiple plaque group. Remodeling is
defined in most clinical studies by a comparison of the lesion
and adjacent reference site (42). The definition of remod-
eling used in the current study, which is based on absolute
values of plaque and vessel diameter at the lesion site, is
novel and will need to be validated and compared with more
established definitions. Currently, the literature about re-
modeling of carotid arteries is limited (15,16), and it is not
clear whether clinical evaluation of carotid remodeling has
an incremental value to conventional risk assessment, high-
sensitivity C-reactive protein, or intima media thickness
(43).
Despite these limitations, the study by Kato et al. (41)
contributes to the growing body of evidence demonstrating
the diffuse nature of atherosclerosis. Plaque accumulation
but also atheroma vulnerability are not confined to a single
vascular bed. This pathophysiologic understanding creates
clinical opportunities for early identification and treatment
of atherosclerosis as well as challenges that come with the
systemic nature of the disease.
Accurate and reproducible methods for detection and
quantification of subclinical coronary atherosclerosis and
plaque vulnerability could identify high-risk patients and
allow serial monitoring during various therapeutic interven-
tions. Several invasive and noninvasive imaging methods are
already used to monitor plaque burden in atherosclerosis
progression/regression studies. Serial intravascular ultra-
sound studies in native coronary arteries describe an atten-
uated increase in plaque volume and changes in plaque
morphology during lipid-lowering treatment (44). Using
noninvasive imaging, the effect of pharmacologic interven-
tion on (calcified) coronary plaque burden has been observed
in CT “calcium scoring” studies (45,46). Recent serial
studies of the femoral artery, carotid artery, and aorta using
B-mode ultrasound and MRI have also demonstrated re-
gression of intimal thickness during lipid-lowering treat-
ment (47–51). These emerging data demonstrate that inva-
sive and noninvasive atherosclerosis imaging can identify
regression of the plaque mass during pharmacologic inter-
vention and, therefore, could be used as an end point in
clinical studies. Methods that would in addition monitor
changes in atheroma composition and vulnerability are still
in their infancies. Whether arterial remodeling can be used
for this purpose will require further study.
Integration of different invasive and noninvasive, mor-
phologic, and functional imaging modalities is needed to
compare the complex atherosclerotic disease patterns across
vascular regions and to correlate the dynamic findings with
clinical outcomes. In the context of a comprehensive clinical
assessment, atherosclerosis imaging has the potential to
improve preventive and therapeutic approaches to coronary,
cerebrovascular, and peripheral atherosclerosis. It potentially
could guide both systemic treatment as well as focal me-
chanical approaches intended to prevent ischemic cardiac
events. However, a rigorous evaluation of these evolving
modalities and their clinical impact will be necessary in the
years ahead.
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